Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanchun Guo

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Future Medicinal Chemistry|November 9, 2019
Design, synthesis and evaluation of belinostat analogs as histone deacetylase inhibitorsJie-Huan Zhang, Madhusoodanan Mottamal, Hai-Shan Jin, et al.
Bioorganic & Medicinal Chemistry|August 20, 2018
Optimization of diarylpentadienones as chemotherapeutics for prostate cancerManee Patanapongpibul, Changde Zhang, Guanglin Chen, et al.
International Journal of Cancer|April 25, 2003
Prognostic significance of reduced expression of beta-N-acetylgalactosaminylated N-linked oligosaccharides in human breast cancerNoriaki Kitamura, Shanchun Guo, Takeshi Sato, et al.
European Journal of Medicinal Chemistry|May 22, 2026
Developing orally active estrogen receptor degraders by conjugation of boronic tamoxifen and cereblon ligandsXianyou Peng, Ahamed Hossain, Peng Ma, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME StudiesJiawang Liu, Nirmal Rajasekaran, Ahamed Hossain, et al.
Cell Communication and Signaling : CCS|July 2, 2025
TRIM21 functions as an oncogene in glioblastoma by transactivating FOSL1 and promoting the ubiquitination of p27Vanajothi Ramar, Rajveer Singh Sidhu, Osei Pako, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate CancerBorui Kang, Madhusoodanan Mottamal, Qiu Zhong, et al.
Molecules (Basel, Switzerland)|June 23, 2016
Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase InhibitionYong Li, Ting-Ting Cao, Shanchun Guo, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor DownregulatorJiawang Liu, Shilong Zheng, Shanchun Guo, et al.
European Journal of Medicinal Chemistry|August 31, 2018
Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agentsXiang Li, Changde Zhang, Shanchun Guo, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Future Medicinal Chemistry|November 9, 2019
Design, synthesis and evaluation of belinostat analogs as histone deacetylase inhibitorsJie-Huan Zhang, Madhusoodanan Mottamal, Hai-Shan Jin, et al.
Bioorganic & Medicinal Chemistry|August 20, 2018
Optimization of diarylpentadienones as chemotherapeutics for prostate cancerManee Patanapongpibul, Changde Zhang, Guanglin Chen, et al.
International Journal of Cancer|April 25, 2003
Prognostic significance of reduced expression of beta-N-acetylgalactosaminylated N-linked oligosaccharides in human breast cancerNoriaki Kitamura, Shanchun Guo, Takeshi Sato, et al.
European Journal of Medicinal Chemistry|May 22, 2026
Developing orally active estrogen receptor degraders by conjugation of boronic tamoxifen and cereblon ligandsXianyou Peng, Ahamed Hossain, Peng Ma, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME StudiesJiawang Liu, Nirmal Rajasekaran, Ahamed Hossain, et al.
Cell Communication and Signaling : CCS|July 2, 2025
TRIM21 functions as an oncogene in glioblastoma by transactivating FOSL1 and promoting the ubiquitination of p27Vanajothi Ramar, Rajveer Singh Sidhu, Osei Pako, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate CancerBorui Kang, Madhusoodanan Mottamal, Qiu Zhong, et al.
Molecules (Basel, Switzerland)|June 23, 2016
Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase InhibitionYong Li, Ting-Ting Cao, Shanchun Guo, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor DownregulatorJiawang Liu, Shilong Zheng, Shanchun Guo, et al.
European Journal of Medicinal Chemistry|August 31, 2018
Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agentsXiang Li, Changde Zhang, Shanchun Guo, et al.
Pageof 7